These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2667968)

  • 61. [Carrier detection, prenatal diagnosis and treatment in adrenogenital syndrome].
    Illy KE; Oosterwijk JC; Christiaens GC; Wit JM
    Ned Tijdschr Geneeskd; 1992 Dec; 136(49):2411-4. PubMed ID: 1470241
    [No Abstract]   [Full Text] [Related]  

  • 62. [Neglected congenital adrenogenital syndrome (AGS) in an adult. A case report (21-hydroxylase deficiency) with a summary of the current status of therapy with reference to adulthood].
    Mackenroth T
    Internist (Berl); 1986 Apr; 27(4):274-8. PubMed ID: 3519519
    [No Abstract]   [Full Text] [Related]  

  • 63. Prenatal fetal adrenal suppression following in utero diagnosis of congenital adrenal hyperplasia.
    Shapiro E; Santiago JV; Crane JP
    J Urol; 1989 Aug; 142(2 Pt 2):663-6; discussion 667-8. PubMed ID: 2746796
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Occurrence of severe striae in adolescents with congenital adrenal hyperplasia and 21-hydroxylation deficiency treated with dexamethasone].
    Guest G; Rappaport R; Philippe F; Thibaud E
    Arch Fr Pediatr; 1983; 40(6):453-6. PubMed ID: 6605132
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prenatal diagnosis and in utero treatment of congenital adrenal hyperplasia: An up-to-date comprehensive review.
    Okpaise OO; Ahn H; Tonni G; Ruano R
    Prenat Diagn; 2024 May; 44(5):635-643. PubMed ID: 38448010
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Genetic counseling and prenatal diagnosis of adrenal hyperplasia caused by 21-hydroxylase deficiency].
    Couillin P
    Presse Med; 1984 Apr; 13(17):1087-90. PubMed ID: 6232534
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prenatal diagnosis and treatment of 21-hydroxylase deficiency.
    Forest MG; David M; Morel Y
    J Steroid Biochem Mol Biol; 1993 Apr; 45(1-3):75-82. PubMed ID: 8481354
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Molecular study of CYP21A2 gene for prenatal diagnosis of congenital adrenal hyperplasia. Report of a family].
    Merino P; Bachega T; Céspedes P; Trejo L; Billerbeck AE; Codner E
    Rev Med Chil; 2007 Nov; 135(11):1450-5. PubMed ID: 18259657
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia.
    Pang S; Clark AT; Freeman LC; Dolan LM; Immken L; Mueller OT; Stiff D; Shulman DI
    J Clin Endocrinol Metab; 1992 Jul; 75(1):249-53. PubMed ID: 1619017
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hydrometrocolpos following prenatal dexamethasone treatment for congenital adrenal hyperplasia (21-hydroxylase deficiency).
    Couper JJ; Hutson JM; Warne GL
    Eur J Pediatr; 1993 Jan; 152(1):9-11. PubMed ID: 8444215
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacologic suppression of the fetal adrenal gland in utero. Attempted prevention of abnormal external genital masculinization in suspected congenital adrenal hyperplasia.
    Evans MI; Chrousos GP; Mann DW; Larsen JW; Green I; McCluskey J; Loriaux DL; Fletcher JC; Koons G; Overpeck J
    JAMA; 1985 Feb; 253(7):1015-20. PubMed ID: 3968825
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses.
    Mercè Fernández-Balsells M; Muthusamy K; Smushkin G; Lampropulos JF; Elamin MB; Abu Elnour NO; Elamin KB; Agrwal N; Gallegos-Orozco JF; Lane MA; Erwin PJ; Montori VM; Murad MH
    Clin Endocrinol (Oxf); 2010 Oct; 73(4):436-44. PubMed ID: 20550539
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term outcome of prenatal dexamethasone treatment of 21-hydroxylase deficiency.
    Lajic S; Nordenström A; Hirvikoski T
    Endocr Dev; 2011; 20():96-105. PubMed ID: 21164263
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prenatal treatment of congenital adrenal hyperplasia : do we have enough evidence?
    Hughes I
    Treat Endocrinol; 2006; 5(1):1-6. PubMed ID: 16396513
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prenatal diagnosis of 11beta-hydroxylase deficiency congenital adrenal hyperplasia.
    Rösler A; Leiberman E; Rosenmann A; Ben-Uzilio R; Weidenfeld J
    J Clin Endocrinol Metab; 1979 Oct; 49(4):546-51. PubMed ID: 314453
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Congenital adrenal hyperplasia.
    Pang S
    Endocrinol Metab Clin North Am; 1997 Dec; 26(4):853-91. PubMed ID: 9429863
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Basic and clinical aspects of congenital adrenal hyperplasia.
    New MI
    J Steroid Biochem; 1987; 27(1-3):1-7. PubMed ID: 3320531
    [TBL] [Abstract][Full Text] [Related]  

  • 78. HLA-A,B,C,DR typing and 17-OHP determination for second trimester prenatal diagnosis of 21-hydroxylase deficient CAH.
    Grosse-Wilde H; Valentine-Thon E; Vögeler U; Passarge E; Lorenzen F; Sippell WG; Bidlingmaier F; Knorr D
    Prenat Diagn; 1988 Feb; 8(2):131-43. PubMed ID: 3258985
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pitfalls in prenatal diagnosis of 21-hydroxylase deficiency by amniotic fluid steroid analysis? A six years experience in 102 pregnancies at risk.
    Forest MG
    Ann N Y Acad Sci; 1985; 458():130-47. PubMed ID: 3879118
    [No Abstract]   [Full Text] [Related]  

  • 80. Nonclassic adrenal hyperplasia due to 21-hydroxylase deficiency.
    Drucker S; New MI
    Pediatr Clin North Am; 1987 Aug; 34(4):1067-81. PubMed ID: 3302893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.